HCA Healthcare officer proposes $594K share sale

The shares were acquired from HCA Healthcare on October 29, 2026, through exercise of a stock appreciation right.

Available on EDGAR 11/04/2026 - 04:28 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

HCA Healthcare, Inc. officer Michael J. Schlosser reported a proposed sale of 1,200 common shares, with an aggregate market value of $593,583 and an approximate sale date of November 4, 2026. The shares were acquired from HCA Healthcare, Inc. on October 29, 2026, through exercise of a stock appreciation right, with compensatory payment; NYSE is listed as the sale exchange.

Key Figures

Common shares to be sold: 1,200 shares Aggregate market value: $593,583 Common shares outstanding: 208,892,500 shares +2 more

5 metrics

Common shares to be sold 1,200 shares Proposed sale by Michael J. Schlosser

Aggregate market value $593,583 Proposed sale

Common shares outstanding 208,892,500 shares HCA Healthcare, Inc.

Approximate sale date November 4, 2026 Proposed sale

Acquisition date October 29, 2026 Shares to be sold

Key Terms

Rule 144, Stock Appreciation Right, Compensatory Payment

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Appreciation Right financial

"Exercise of a Stock Appreciation Right"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

Compensatory Payment financial

"Compensatory Payment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the planned HCA share sale by Michael J. Schlosser?

Michael J. Schlosser reported a proposed sale of 1,200 HCA common shares, with an aggregate market value of $593,583, an approximate sale date of November 4, 2026, and NYSE listed as the exchange.

How were the shares in Michael J. Schlosser's planned HCA sale acquired?

The 1,200 shares were acquired from HCA Healthcare on October 29, 2026, through exercise of a stock appreciation right; the stated nature of payment was compensatory payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002149484
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HCA Healthcare, Inc.
SEC File Number	001-11239
Address of Issuer	One Park Plaza Nashville TENNESSEE 37203
Phone	615-344-9551
Name of Person for Whose Account the Securities are To Be Sold	Michael J Schlosser
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3455 Peachtree Road NE Suite 1000 Atlanta GA 30326	1200	593583	208892500	11/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/29/2026	Exercise of a Stock Appreciation Right	HCA Healthcare, Inc.			1200	10/29/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Michael J Schlosser
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)